These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 15704999)

  • 21. Relationship between depression severity entry criteria and antidepressant clinical trial outcomes.
    Khan A; Schwartz K; Kolts RL; Ridgway D; Lineberry C
    Biol Psychiatry; 2007 Jul; 62(1):65-71. PubMed ID: 17141744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A meta-analysis of early sustained response rates between antidepressants and placebo for the treatment of major depressive disorder.
    Papakostas GI; Perlis RH; Scalia MJ; Petersen TJ; Fava M
    J Clin Psychopharmacol; 2006 Feb; 26(1):56-60. PubMed ID: 16415707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
    Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y
    J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Placebo-controlled, antidepressant clinical trials cannot be shortened to less than 4 weeks' duration: a pooled analysis of randomized clinical trials employing a diagnostic odds ratio-based approach.
    Tedeschini E; Fava M; Papakostas GI
    J Clin Psychiatry; 2011 Jan; 72(1):98-113. PubMed ID: 21208576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy in long-term treatment of depression.
    Montgomery SA
    J Clin Psychiatry; 1996; 57 Suppl 2():24-30. PubMed ID: 8626360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression.
    Emslie GJ; Rush AJ; Weinberg WA; Kowatch RA; Hughes CW; Carmody T; Rintelmann J
    Arch Gen Psychiatry; 1997 Nov; 54(11):1031-7. PubMed ID: 9366660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Double-blind treatment of major depression with dehydroepiandrosterone.
    Wolkowitz OM; Reus VI; Keebler A; Nelson N; Friedland M; Brizendine L; Roberts E
    Am J Psychiatry; 1999 Apr; 156(4):646-9. PubMed ID: 10200751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of antidepressant trials using active and inert placebos.
    Moncrieff J
    Int J Methods Psychiatr Res; 2003; 12(3):117-27. PubMed ID: 12953139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double-blind, placebo-controlled study of paroxetine in depressed outpatients.
    Kiev A
    J Clin Psychiatry; 1992 Feb; 53 Suppl():27-9. PubMed ID: 1531818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A fixed-dose (300 mg) efficacy study of bupropion and placebo in depressed outpatients.
    Lineberry CG; Johnston JA; Raymond RN; Samara B; Feighner JP; Harto NE; Granacher RP; Weisler RH; Carman JS; Boyer WF
    J Clin Psychiatry; 1990 May; 51(5):194-9. PubMed ID: 2110559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The safety and efficacy of paroxetine compared with placebo in a double-blind trial of depressed outpatients.
    Claghorn JL
    J Clin Psychiatry; 1992 Feb; 53 Suppl():33-5. PubMed ID: 1531821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical features of depressed patients who do and do not improve with placebo.
    Brown WA; Johnson MF; Chen MG
    Psychiatry Res; 1992 Mar; 41(3):203-14. PubMed ID: 1594707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A double-blind comparison of Org 3770, amitriptyline, and placebo in major depression.
    Bremner JD
    J Clin Psychiatry; 1995 Nov; 56(11):519-25. PubMed ID: 7592505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial.
    Detke MJ; Lu Y; Goldstein DJ; Hayes JR; Demitrack MA
    J Clin Psychiatry; 2002 Apr; 63(4):308-15. PubMed ID: 12000204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression.
    Schmidt PJ; Daly RC; Bloch M; Smith MJ; Danaceau MA; St Clair LS; Murphy JH; Haq N; Rubinow DR
    Arch Gen Psychiatry; 2005 Feb; 62(2):154-62. PubMed ID: 15699292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of pattern analysis to predict differential relapse of remitted patients with major depression during 1 year of treatment with fluoxetine or placebo.
    Stewart JW; Quitkin FM; McGrath PJ; Amsterdam J; Fava M; Fawcett J; Reimherr F; Rosenbaum J; Beasley C; Roback P
    Arch Gen Psychiatry; 1998 Apr; 55(4):334-43. PubMed ID: 9554429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Review of the use of pattern analysis to differentiate true drug and placebo responses.
    Rothschild R; Quitkin FM
    Psychother Psychosom; 1992; 58(3-4):170-7. PubMed ID: 1488501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial.
    Lecrubier Y; Clerc G; Didi R; Kieser M
    Am J Psychiatry; 2002 Aug; 159(8):1361-6. PubMed ID: 12153829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.
    Calabrese JR; Bowden CL; Sachs GS; Ascher JA; Monaghan E; Rudd GD
    J Clin Psychiatry; 1999 Feb; 60(2):79-88. PubMed ID: 10084633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features.
    Tollefson GD; Holman SL; Sayler ME; Potvin JH
    J Clin Psychiatry; 1994 Feb; 55(2):50-9. PubMed ID: 8077155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.